Formation of myeloid bodies in rat liver lysosomes after chloroquine administration

https://doi.org/10.1016/0014-4800(68)90037-3Get rights and content

Abstract

When single daily doses (120 mg/kg) of chloroquine sulphate were given to rats, histochemical and ultrastructural investigations demonstrated a sequence of changes in lysosomes of the liver cell. After the first dose, the liver showed an initial loss of particulate β-glucuronidase and acid phosphatase activities (at 1–3 hours) which was most distinct in the periportal area. By 6–24 hours numerous lysosomes with and without recognizable cytoplasmic organelles (autophagic vacuoles and myeloid bodies, were present.

After the second and third doses of chloroquine, the lysosomes increased in size and the majority contained myelin figures. Considerable lysosomal enzyme activity was observed in the periphery of the organelle. Further daily doses produced an increasing amount of undegraded sequestrated material and loss of particulate enzyme staining. There was no demonstrable increase in neutral fat, but a progressive increase in what was probably phospholipid was observed, commencing in those areas of the hepatic lobule showing initial loss of lysosomal enzyme activity. The distributional changes of the phospholipid inclusions correspond closely with those seen for the lysosomal hydrolases. In the highest dosage administered, loss of glycogen occurred in the centrilobular cells, which also showed degenerative changes.

We postulate that chloroquine initially labilizes the lysosomal membrane, releasing lysosomal enzymes and initiating autophagy thought responsible for sequenstration of cytoplasmic material. Multiple treatment induces stability of lysosomal membranes and probably impedes entry of enzymes into these organelles, resulting in accumulation of undegraded sequestrated material.

References (26)

  • M. Fedorka

    Effect of chloroquine on morphology of leukocytes and pancreatic exocrine cells from the rat

    Lab. Invest.

    (1968)
  • J.O. Gabourel

    Effects of hydroxychloroquine on the growth of mammalian cells in vitro

    J. Pharmacol. Exptl. Ther.

    (1963)
  • A.M. Glauert

    The fixation and embedding of biological specimens

  • Cited by (89)

    • The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway

      2020, Biochimie
      Citation Excerpt :

      First, phospholipid and cholesterol can reach the lysosomes either by (1) the uptake of extracellular material such as lipoproteins which enter the cell by adsorptive endocytosis [113] or surface transport [114], or by (2) interaction with intracellular membranes (autophagy) [115]. Examination of liver tissue following treatment with CQ has shown evidence for increased autophagy [116–119], and it is likely that the phospholipids that accumulate in lysosomes are mostly of intracellular origin. Secondly, phospholipid modification and degradation by lysosomal enzymes may be impaired.

    • Ultraviolet B radiation affects epithelial cell morphology and ultrastructure in the hepatopancreas of the freshwater decapod Macrobrachium olfersii

      2020, Ecotoxicology and Environmental Safety
      Citation Excerpt :

      Furthermore, the formation of concentric membranes in F- and R-cells was observed after UVB radiation. This form of membrane is formed by concentric multilayered lipids, and may be involved in organelle and cell membrane degeneration due to alterations in lipid bilayers caused by stressors (Abraham et al., 1968; Jao et al., 1983), or they may indicate intermediate lysosome stages, involved in autophagy. Vacuolization in the cytoplasm of F- and R-cells also observed after UVB radiation may compromise normal prawn metabolism, disturbing the synthesis and release of important molecules, such as digestive enzymes, lipoproteins, vitellogenin, hemocyanin and defenses molecules required for growth and reproduction (Subramoniam, 2011; Vogt, 1994).

    • Antimalarials in rheumatic diseases

      1990, Bailliere's Clinical Rheumatology
    View all citing articles on Scopus
    View full text